Top

Published in:

01-04-2012 | Research

Silencing Poly (ADP-Ribose) Glycohydrolase (PARG) Expression Inhibits Growth of Human Colon Cancer Cells In Vitro via PI3K/Akt/NFκ-B Pathway

Published in: Pathology & Oncology Research | Issue 2/2012

Abstract

Poly ADP-ribose polymerase (PARP) which is closely related to Poly ADP-ribose glycohydrolase (PARG) has already been thoroughly investigated in both experimental and clinical cancer trials compared to the latter. Nevertheless, in this experiment the importance of PARG expression was highlighted; whereby it is being silenced via lentivirus vector-mediated short hairpin RNA (shRNA). MTT assay showed that there was an inhibition in human Lovo colon cancer cell growth and flow cytometry demonstrated an increase in the population of cells in G₀/G₁ phase with a decrease in the S phase in transfected Lovo cells. Furthermore, our results suggested that the effect of silencing PARG leads to the inhibition of PARP expression; related to a decrease in the expression of Nuclear Factor Kappa-B (NFκ-B) with an increase in Akt⁴⁷³ phosphorylation; suggesting that the Phosphoinositol 3-kinase (PI3K)/Akt/NFκ-B pathway is important for cellular growth and proliferation. Hence, this study emphasizes and converges on the relevance of silencing PARG which inhibits growth of human colonic cancer cells via PI3K/Akt/NFκ-B pathway; as colon carcinoma remains to be amongst one of the commonest cancers throughout the world with high morbidity and mortality rates.

Blenn C, Althaus FR, Malanga M (2006) Poly (ADP-ribose) glycohydrolase silencing protects against H₂O₂-induced cell death. Biochem J 396:419–429PubMedCrossRef

Koh DW, Lawler AM, Poitras MF et al (2004) Failure to degrade poly (ADP-ribose) increased sensitivity to cytotoxicity and early embryonic lethality. PNAS 101:17699–17704PubMedCrossRef

Poitras MF, Koh DW, Yu SW et al (2007) Spatial and functional relationship between poly (ADP-ribose) polymerase-1 and Poly (ADP-ribose) glycohydrolase in the brain. Neuroscience 148:198–211PubMedCrossRef

Meyer RG, Meyer-Ficca ML, Jacobson EL, Jacobson MK (2003) Human poly (ADP-ribose) glycohydrolase (PARG) gene and the common promoter sequence it shares with inner mitochondrial membrane translocase 23 (TIM23). Gene 314:181–190PubMedCrossRef

Fisher AEO, Hochegger H, Takeda S et al (2007) Poly (ADP-ribose) polymerase 1 accelerates single-strand break repair in concert with poly (ADP-ribose) glycohydrolase. Mol Cell Biol 27:5597–5605PubMedCrossRef

Cohausz O, Blenn C, Malanga M et al (2008) The roles of poly (ADP-ribose)-metabolising enzymes in alkylation-induced cell death. Cell Mol Life Sci 65:644–655PubMedCrossRef

Frizzell KM, Gamble MJ, Berrocal JG (2009) Global analysis of transcriptional regulation by poly (ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells. J Biol Chem 284:33926–33938PubMedCrossRef

Gagne JP, Moreel X, Gagne P et al (2009) Proteomic investigation of phosphorylation sites in poly (ADP-ribose) polymerase-1 and poly (ADP-ribose) glycohydrolase. J Proteome Res 8:1014–1029PubMedCrossRef

Palfi A, Toth A, Kulcsar G et al (2005) The role of akt and mitogen-activated protein kinase systems in the protective effect of poly (ADP-Ribose) polymerase inhibition in langendorff perfused and in isoproterenol-damaged rat hearts. JPET 315:273–282CrossRef

10.

Tapodi A, Debreceni B, Hanto K et al (2005) Pivotal role of Akt activation in mitochondrial protection and cell survival by poly (ADP-ribose) polymerase-1 inhibition in oxidative stress. JBC 280:35767–35775CrossRef

11.

Veres B, Gallyas F Jr, Varbiro G et al (2003) Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol 65:1373–1382PubMedCrossRef

12.

LoPiccolo J, Granville CA, Gills JJ et al (2007) Targeting Akt in cancer therapy. Anti-cancer drugs 18:861–874PubMed

13.

Bader AG, Khang S, Li Z et al (2005) Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5:921–929PubMedCrossRef

14.

Li B, Cheung PY, Wang X et al (2007) Id-1 activation of PI3K/Akt/NFkB signaling pathway and its significance in promoting survival of esophageal cancer cells. Carcinogenesis 28:2313–2320PubMedCrossRef

15.

Asano T, Yao Y, Zhu J et al (2004) The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells. Oncogene 23:8571–8580PubMedCrossRef

16.

Kane LP, Shapiro VS, Stokoe D et al (1999) Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol 9:601–604PubMedCrossRef

17.

Romashkova JA, Makarov SS (1999) NF-kappaB is a target of AKT in antiapoptotic PDGF signalling. Nature 401:86–90PubMedCrossRef

18.

Virag L, Szabo C (2002) The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375–429PubMedCrossRef

19.

Li M, Threadgill MD, Wang YL, Cai L, Lin X (2009) A poly (ADP-ribose) polymerase inhibition down-regulates expression of metastasis-related genes in CT26 colon carcinoma cells. Pathobiology 76:108–116PubMedCrossRef

20.

Lin L, Li J, Wang YL et al (2009) Relationship of PARG with colorectal carcinoma PARP, VEGF and b-FGF in colorectal carcinoma. Chin J Cancer Res 21:135–141CrossRef

21.

Tulin A, Naumova NM, Menon AK et al (2006) Drosophilia poly (ADP-Ribose) glycohydrolase mediates chromatin structure and SIR2-dependent silencing. Genetics 172:363–371PubMedCrossRef

22.

Erdelyi K, Bai P, Kovacs I et al (2009) Dual role of poly(ADP-ribose) glycohydrolase in the regulation of cell death in oxidatively stresses A549 cells. FASEB 23:3553–3563CrossRef

23.

Fauzee NJS, Juan P, Wang YL (2010) PARP and PARG inhibitors-new therapeutic targets in cancer treatment. Pathol Oncol Res 4:469–478CrossRef

24.

Karin M, Cao Y, Greten FR et al (2002) NFκB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301–310PubMedCrossRef

25.

Veres B, Radnai B, Gallyas F et al (2004) Regulation of kinase cascades and transcripition factors by a poly (ADP-Ribose) polymerase-1 inhibitor, 4-Hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice. JPET 310:247–255CrossRef

26.

Kovacs K, Toth A, Deres P et al (2006) Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia–reperfusion. Biochem Pharmacol 71:441–452PubMedCrossRef

27.

Bar-Shai M, Carmeli E, Reznick AZ (2005) The role of NF-κB in protein breakdown in immobilization, aging, and exercise from basic processes to promotion of health. Ann NY Acad Sci 1057:431–447PubMedCrossRef

28.

Cai D, Frantz JD, Tawa NE et al (2004) IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell 119:285–298PubMedCrossRef

29.

Xian L, Guang-jie D, Wang Y et al (2010) Expressions of Poly (ADP-ribose) Glycohydrolase (PARG) and membrane Type1 Matrix Metalloproteinase (MT1-MMP) in Colorectal Carcinoma. Chin J Cancer Res 22:186–193CrossRef

30.

Olashaw NE, Kowalik TF, Huang EH et al (1992) Induction of NF-KB-Like Activity by Platelet-Derived Growth Factor in Mouse Fibroblasts. Mol Biol Cell 3:1131–1139PubMed

31.

Bushdid PB, Chen CL, Brantley DM et al (2001) NF-κB mediates FGF signal regulation of msx-1 expression. Dev Biol 237:107–115PubMedCrossRef

32.

Hayden MS, West AP, Ghosh S (2006) NF-κB and the immune response. Oncogene 119:6758–6780CrossRef

33.

Bai D, Ueno L, Vogt PK (2009) Akt-mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt. Int J Cancer 125:2863–2870PubMedCrossRef

34.

Guha M, Mackman N (2002) The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. JBC 277:32124–32132CrossRef

35.

Tamizhselvi R, Sun J, Koh YH et al (2009) Effect of hydrogen sulfide on the phosphatidylinositol 3-kinase-protein kinase B pathway and on caerulein-induced cytokine production in isolated mouse pancreatic acinar cells. JPET 329:1166–1178CrossRef

36.

Zhou H, Qian J, Li C et al (2011) Attenuation of cardiac dysfunction by HSPA12B in endotoxin-induced sepsis in mice through a PI3K-dependent mechanism. Cardiovasc Res 89:109–118PubMedCrossRef

37.

Zhao L, Lee JY, Hwang DH (2008) The phosphatidylinositol 3-kinase/Akt pathway negatively regulates Nod2-mediated NF-kB pathway. Biochempharm 75:1515–1525

Title: Silencing Poly (ADP-Ribose) Glycohydrolase (PARG) Expression Inhibits Growth of Human Colon Cancer Cells In Vitro via PI3K/Akt/NFκ-B Pathway
Publication date: 01-04-2012
Published in: Pathology & Oncology Research / Issue 2/2012
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-011-9428-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2012

Hexokinase II in CD133+ and CD133- Hepatoma BEL-7402 Cells

Modern Trends into the Epidemiology and Screening of Ovarian Cancer. Genetic Substrate of the Sporadic Form

Indeterminate Cell Histiocytosis in a Pediatric Patient: Successful Treatment with Thalidomide

Prognostic Value of Matrix Metalloproteinase-1/ Proteinase-Activated Receptor-1 Signaling Axis in Hepatocellular Carcinoma

Clinical and Biological Significance of Never in Mitosis Gene A-Related Kinase 6 (NEK6) Expression in Hepatic Cell Cancer

CD10 Expression in Epithelial and Stromal Cells of Non-small Cell Lung Carcinoma (NSCLC): A Clinic and Pathologic Correlation

Keynote webinar | Spotlight on antibody–drug conjugates in cancer